News

Gilead Sciences (NASDAQ:GILD) Delivers Strong Q4 Numbers

Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 6.4% year on year to $7.57 billion. The company expects the full year’s revenue to be around $28.4 billion, close to analysts’ estimates. Its non-GAAP profit of $1.90 per share was 11.7% above analysts’ consensus estimates.

Sensata Technologies (NYSE:ST) Q4: Beats On Revenue, Stock Soars

Sensor manufacturer Sensata Technology (NYSE:ST) reported Q4 CY2024 results beating Wall Street’s revenue expectations, but sales fell by 8.5% year on year to $907.7 million. On the other hand, next quarter’s revenue guidance of $880 million was less impressive, coming in 1.7% below analysts’ estimates. Its non-GAAP profit of $0.76 per share was 1.4% above analysts’ consensus estimates.

Why Shopify (SHOP) Stock Is Up Today

Shares of e-commerce software platform Shopify (NYSE:SHOP) jumped 4.1% in the afternoon session after the company reported impressive fourth-quarter results that exceeded analysts' gross merchandise volume expectations, leading to a solid sales beat. The improved top-line growth was driven by growth with existing customers and their businesses, better payment monetization, and strength in Europe. The result reflected the growing adoption of products like Shopify Pay and Shopify Plus, which can a